Research
Hormonal
Oxyntomodulin (OXM) requires functional GLP-1 receptors in the CNS to induce brown adipose tissue thermogenesis, despite also binding to glucagon receptors.
If using Oxyntomodulin (or dual agonists with strong OXM activity), the GLP-1 receptor pathway is essential for activating brown fat. Simply activating glucagon receptors is not enough to trigger this specific fat-burning mechanism.
GoodQualifiesHIGH confidence
Despite being a GCG receptor agonist, OXM requires GLP-1R activation to induce iBAT thermogenesis.
Why this rating
Clear genetic knockout evidence distinguishing receptor roles.
Source
Direct Control of Brown Adipose Tissue Thermogenesis by Central Nervous System Glucagon-Like Peptide-1 Receptor Signaling
Sarah H. Lockie et al. · Diabetes · 2012
DOI 10.2337/db11-1556
mechanism_onlyCited 232×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →